PCI

Photo

PCI Pharma Boosts Services with Bedford Expansion

US-based PCI Pharma Services, a multinational CDMO, is spending $100 million to enhance its capacity and capabilities in aseptic liquid fill-finish and sterile lyophilization at its campus in Bedford, New Hampshire. The move follows the acquisition of Lyophilization Services of New England (LSNE) last December, which added the Bedford site to PCI’s network.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.